» Articles » PMID: 26825001

Cancer and Aging: Epidemiology and Methodological Challenges

Overview
Journal Acta Oncol
Specialty Oncology
Date 2016 Jan 31
PMID 26825001
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Epidemiological cancer data shed light on key questions within basic science, clinical medicine and public health. For decades, Denmark has had linkable health registers that contain individual level data on the entire population with virtually complete follow-up. This has enabled high quality studies of cancer epidemiology and minimized the challenges often faced in many countries, such as uncertain identification of the study base, age misreporting, and low validity of the cancer diagnoses. However, methodological challenges still remain to be addressed, especially in cancer epidemiology studies among the elderly and the oldest-old. For example, a characteristic pattern for many cancer types is that the incidence increases up to a maximum at about ages 75-90 years and is then followed by a decline or a leveling off at the oldest ages. It has been suggested that the oldest individuals may be asymptomatic, or even insusceptible to cancer. An alternative interpretation is that this pattern is an artifact due to lower diagnostic intensity among the elderly and oldest-old caused by higher levels of co-morbidities in this age group. Currently, the available cancer epidemiology data are not able to provide clear evidence for any of these hypotheses.

Citing Articles

Effect of census-based correction of population figures on mortality rates in Germany.

Stang A, Deckert M Popul Health Metr. 2025; 23(1):1.

PMID: 39871269 PMC: 11773962. DOI: 10.1186/s12963-025-00361-5.


Global Disparities of Cancer and Its Projected Burden in 2050.

Bizuayehu H, Ahmed K, Kibret G, Dadi A, Belachew S, Bagade T JAMA Netw Open. 2024; 7(11):e2443198.

PMID: 39499513 PMC: 11539015. DOI: 10.1001/jamanetworkopen.2024.43198.


Advantages, barriers, and cues to advance care planning engagement in elderly patients with cancer and family members in Southern Thailand: a qualitative study.

Sripaew S, Assanangkornchai S, Limsomwong P, Kittichet R, Vichitkunakorn P BMC Palliat Care. 2024; 23(1):211.

PMID: 39164698 PMC: 11337743. DOI: 10.1186/s12904-024-01536-x.


Anti-Angiogenic Tyrosine Kinase Inhibitor-Related Toxicities Among Cancer Patients: A Systematic Review and Meta-Analysis.

Van Nguyen T, Hamdan D, Falgarone G, Do K, Le Q, Pamoukdjian F Target Oncol. 2024; 19(4):533-545.

PMID: 38761350 DOI: 10.1007/s11523-024-01067-8.


The Marsden Morbidity Index: the derivation and validation of a simple risk index scoring system using cardiopulmonary exercise testing variables to predict morbidity in high-risk patients having major cancer surgery.

Nawoor-Quinn Z, Oliver A, Raobaikady R, Mohammad K, Cone S, Kasivisvanathan R Perioper Med (Lond). 2022; 11(1):48.

PMID: 36138428 PMC: 9494857. DOI: 10.1186/s13741-022-00279-8.


References
1.
Tyner S, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H . p53 mutant mice that display early ageing-associated phenotypes. Nature. 2002; 415(6867):45-53. DOI: 10.1038/415045a. View

2.
Christensen K, Pedersen J, Hjelmborg J, Vaupel J, Stevnsner T, Holm N . Cancer and longevity--is there a trade-off? A study of cooccurrence in Danish twin pairs born 1900-1918. J Gerontol A Biol Sci Med Sci. 2012; 67(5):489-94. PMC: 3326241. DOI: 10.1093/gerona/gls087. View

3.
OBrien E, Kerber R, Smith K, Mineau G, Boucher K, Reed D . Familial mortality in the Utah population database: characterizing a human aging phenotype. J Gerontol A Biol Sci Med Sci. 2007; 62(8):803-12. DOI: 10.1093/gerona/62.8.803. View

4.
Harding C, Pompei F, Wilson R . Peak and decline in cancer incidence, mortality, and prevalence at old ages. Cancer. 2011; 118(5):1371-86. DOI: 10.1002/cncr.26376. View

5.
Boscoe F . Subdividing the age group of 85 years and older to improve US disease reporting. Am J Public Health. 2008; 98(7):1167-70. PMC: 2424097. DOI: 10.2105/AJPH.2008.133900. View